SCG3 and Parkinson disease: The findings here in MPTP/MPP+-induced PD models accord with our previous work in the dopaminergic cell model induced by another parkinsonian toxin PQ, which showed a significant number decrease and trafficking impairment of Scg3 and CgA positive SGs [21].